Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma.
Tortora R, Farella N, Morisco F, Coppola C, Izzo F, Salomone Megna A, Federico A, Messina V, Nardone G, Piai G, Ragone E, Adinolfi LE, D'Adamo G, Stanzione M, Francica G, Torre P, De Girolamo V, Coppola N, Guarino M, Dallio M, Rocco L, Di Costanzo GG; Progetto Epatocarcinoma Campania Group. Tortora R, et al. Among authors: di costanzo gg. Eur J Gastroenterol Hepatol. 2023 Jul 1;35(7):734-741. doi: 10.1097/MEG.0000000000002549. Epub 2023 Apr 4. Eur J Gastroenterol Hepatol. 2023. PMID: 37115974 Free PMC article.
Refining sorafenib therapy: lessons from clinical practice.
Bolondi L, Craxi A, Trevisani F, Daniele B, Di Costanzo GG, Fagiuoli S, Cammà C, Bruzzi P, Danesi R, Spandonaro F, Boni C, Santoro A, Colombo M. Bolondi L, et al. Among authors: di costanzo gg. Future Oncol. 2015;11(3):449-65. doi: 10.2217/fon.14.261. Epub 2014 Oct 31. Future Oncol. 2015. PMID: 25360997 Review.
Seronegative occult HBV reactivation complicated with fulminant acute liver failure after rituximab for chronic inflammatory demyelinating polyneuropathy.
Buonomo AR, Viceconte G, Scotto R, De Angelis M, Tozza S, Manganelli F, Lanza AG, Di Costanzo GG, Gentile I. Buonomo AR, et al. Among authors: di costanzo gg. Infect Dis (Lond). 2020 Mar;52(3):216-218. doi: 10.1080/23744235.2019.1693624. Epub 2019 Nov 26. Infect Dis (Lond). 2020. PMID: 31766959 No abstract available.
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B.
Lampertico P, Viganò M, Di Costanzo GG, Sagnelli E, Fasano M, Di Marco V, Boninsegna S, Farci P, Fargion S, Giuberti T, Iannacone C, Regep L, Massetto B, Facchetti F, Colombo M; PegBeLiver Study Group. Lampertico P, et al. Among authors: di costanzo gg, di marco v. Gut. 2013 Feb;62(2):290-8. doi: 10.1136/gutjnl-2011-301430. Epub 2012 Aug 2. Gut. 2013. PMID: 22859496 Clinical Trial.
A rare cause of diuretic refractory ascites.
Di Costanzo GG, Ragozzino A, Niola R, Maglione F, Ascione A. Di Costanzo GG, et al. Gut. 2006 Jan;55(1):53, 73. doi: 10.1136/gut.2005.067868. Gut. 2006. PMID: 16344575 Free PMC article. No abstract available.
Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S; Italian Association of the Study of the Liver Disease (AISF). Stroffolini T, et al. Am J Gastroenterol. 2008 Aug;103(8):1966-72. doi: 10.1111/j.1572-0241.2008.01912.x. Epub 2008 Jul 12. Am J Gastroenterol. 2008. PMID: 18637087
78 results